LOW-DOSE AUGMENTATION WITH BUPRENORPHINE INCREASES EMOTIONAL REACTIVITY BUT NOT REWARD ACTIVITY IN TREATMENT RESISTANT MID- AND LATE-LIFE DEPRESSION

Low-dose augmentation with buprenorphine increases emotional reactivity but not reward activity in treatment resistant mid- and late-life depression

Buprenorphine is currently being studied for treatment-resistant depression because of its rapid effect, relative safety, and unique pharmacodynamics.To understand the neural impact of buprenorphine in depression, we examined acute limbic and reward circuit changes during an intervention with low-dose buprenorphine augmentation pharmacotherapy.Mid

read more

Nature and Composition of Earnings Reported by Health Economists and Related Professionals: Gender, Education, and job Characteristics Matter

Background Despite the fast growth of the workforce comprising health economics (HE), outcomes research (OR), and market access (MA) professionals, little is known about their earnings determination.Only three studies have examined their earnings and none has considered the number of hours worked, traditionally a critical component of income determ

read more